Abstract:Synthetic Biology is a growing field which holds great promise in several areas of application. However, it also poses serious risks for human health and the environment that must be anticipated in order to develop effective prevention and management measures. Here, the current situation on biosafety and biosecurity in this scientific field is reviewed. Biosafety concerns mainly relate to the damaging effects for workers and the environment that could result from accidental interactions with dangerous biologic… Show more
“…Overall, the benefit assessment of scientists builds on arguments associated with the multiple broader movements, while the risk assessment of scientists is mostly derived from one movement, synthetic biology movement. According to Gómez‐Tatay & Hernández‐Andreu (, p. 26), synthetic biology has three main risk branches: “protocells, xenobiology, and DIYsynbio.”…”
Section: Resultsmentioning
confidence: 99%
“…The dual‐use view is often adopted when discussing the promises and risks of the DIYBM. On a fundamental level, the DIYBM is a risk because it increases the dual‐use risk and the risk for unintended negative consequences since it increases the probability of accidents by practitioners with no biosafety training “manipulating organisms in their homes” and possibly pursuing “reckless projects” (Gómez‐Tatay & Hernández‐Andreu, , p. 26) without “regulatory devices such as professional codes, export controls, or classification” (Evans, , p. 272). However, Jefferson, Lentzos, and Marris () argue that current advances in DNA synthesis are far from enabling the DIYBM to be a real risk for biosecurity.…”
Section: Resultsmentioning
confidence: 99%
“…From the positive perspective, scientists emphasize the potential of the DIYBM to facilitate a more innovative, transparent, and collaborative way of doing science and sharing knowledge by promoting citizen science and decentralized, affordable access to biotechnology (Gómez‐Tatay & Hernández‐Andreu, ).…”
Human enhancement aims at improving individual human performance through science‐based or technology‐based interventions in the human body. For various decades, associated research and applications/interventions were performed in conventional settings (e.g., research institutes) through conventional regulated and controlled procedures (e.g., clinical trials). In the last decade there has been an emergence of science activities grounded on emerging technologies used in unconventional settings (e.g., households; community labs), often through unconventional unregulated and uncontrolled procedures (e.g., self‐administration of substances). The Do‐It‐Yourself Biology or Biohacking movement is an example of communities supportive of such activities, which use emerging technologies such as the CRISPR technique. Among others, these can have other or self‐enhancement goals. Because such activities are anticipated to increase in the future, and due to the methods novelty, lack of regulation, quality, and safety control, there is uncertainty regarding personal and social consequences. Thus, these can be considered to present an emerging risk to human health and the environment. A first step in risk regulation is considering ethical aspects of emerging technologies use, which has been implemented. A second step to sustain subsequent evidence‐based risk management and risk communication to citizen scientists, is necessary. It should involve risk assessment by experts and an understanding of public views on human enhancement technologies. Due to the scarce literature, gathering information to support this step was the goal of a non‐systematic literature review. This focused on internal enhancements through substances intake and human body manipulations, specifically DIY biology/biohacking activities with this goal.
“…Overall, the benefit assessment of scientists builds on arguments associated with the multiple broader movements, while the risk assessment of scientists is mostly derived from one movement, synthetic biology movement. According to Gómez‐Tatay & Hernández‐Andreu (, p. 26), synthetic biology has three main risk branches: “protocells, xenobiology, and DIYsynbio.”…”
Section: Resultsmentioning
confidence: 99%
“…The dual‐use view is often adopted when discussing the promises and risks of the DIYBM. On a fundamental level, the DIYBM is a risk because it increases the dual‐use risk and the risk for unintended negative consequences since it increases the probability of accidents by practitioners with no biosafety training “manipulating organisms in their homes” and possibly pursuing “reckless projects” (Gómez‐Tatay & Hernández‐Andreu, , p. 26) without “regulatory devices such as professional codes, export controls, or classification” (Evans, , p. 272). However, Jefferson, Lentzos, and Marris () argue that current advances in DNA synthesis are far from enabling the DIYBM to be a real risk for biosecurity.…”
Section: Resultsmentioning
confidence: 99%
“…From the positive perspective, scientists emphasize the potential of the DIYBM to facilitate a more innovative, transparent, and collaborative way of doing science and sharing knowledge by promoting citizen science and decentralized, affordable access to biotechnology (Gómez‐Tatay & Hernández‐Andreu, ).…”
Human enhancement aims at improving individual human performance through science‐based or technology‐based interventions in the human body. For various decades, associated research and applications/interventions were performed in conventional settings (e.g., research institutes) through conventional regulated and controlled procedures (e.g., clinical trials). In the last decade there has been an emergence of science activities grounded on emerging technologies used in unconventional settings (e.g., households; community labs), often through unconventional unregulated and uncontrolled procedures (e.g., self‐administration of substances). The Do‐It‐Yourself Biology or Biohacking movement is an example of communities supportive of such activities, which use emerging technologies such as the CRISPR technique. Among others, these can have other or self‐enhancement goals. Because such activities are anticipated to increase in the future, and due to the methods novelty, lack of regulation, quality, and safety control, there is uncertainty regarding personal and social consequences. Thus, these can be considered to present an emerging risk to human health and the environment. A first step in risk regulation is considering ethical aspects of emerging technologies use, which has been implemented. A second step to sustain subsequent evidence‐based risk management and risk communication to citizen scientists, is necessary. It should involve risk assessment by experts and an understanding of public views on human enhancement technologies. Due to the scarce literature, gathering information to support this step was the goal of a non‐systematic literature review. This focused on internal enhancements through substances intake and human body manipulations, specifically DIY biology/biohacking activities with this goal.
“…183 Experts are calling for more regional and even global harmonization and collaborations. 177,178,184 For instance, in the face of a novel pathogen, coordinated real-time communication and data sharing across borders will make biosecurity surveillance and response more effective. 184 In order to achieve this, it is important to have researchers and regulators from different countries align their understanding of the benefits and risks of synthetic biology, and lay out common frameworks for synthetic biology regulations and biosecurity surveillance.…”
Synthetic biology research and technology translation has garnered increasing interest from the governments and private investors in Asia, where the technology has great potential in driving a sustainable bio-based economy. This Perspective reviews the latest developments in the key enabling technologies of synthetic biology and its application in bio-manufacturing, medicine, food and agriculture in Asia. Asia-centric strengths in synthetic biology to grow the bio-based economy, such as advances in genome editing and the presence of biofoundries combined with the availability of natural resources and vast markets, are also highlighted. The potential barriers to the sustainable development of the field, including inadequate infrastructure and policies, with suggestions to overcome these by building public-private partnerships, more effective multilateral collaborations and well-developed governance framework, are presented. Finally, the roles of technology, education and regulation in mitigating potential biosecurity risks are examined. Through these discussions, stakeholders from different groups, including academia, industry and government, are expectantly better positioned to contribute towards the establishment of innovation and bioeconomy hubs in Asia.
“…The high-throughput evaluation of toxin mode of action as well as the diagnosis and decontamination of disulfide rich toxins, either natural or man-made, is required for public health safety. Rapid advances in synthetic biology have created challenges in determining the health risks posed by natural toxins or modified toxins with even higher pathogenicity [Gomez-Tatay and Hernandez-Andreu, 2019]. Thus, in tandem with high-throughput screening for therapeutic design, it is necessary to also be able to perform high-throughput screening for threat identification and determination of toxin targets and mechanisms of action.…”
Many toxins are short, cysteine-rich peptides that are of great interest as novel therapeutic leads and of great concern as lethal biological agents due to their high affinity and specificity for various receptors involved in neuromuscular transmission. To perform initial candidate identification for design of a drug impacting a particular receptor or for threat assessment as a harmful toxin, one requires a set of candidate structures of reasonable accuracy with potential for interaction with the target receptor. In this article, we introduce a graph-based algorithm for identifying good extant template structures from a library of evolutionarily-related cysteine-containing sequences for structural determination of target sequences by homology modeling. We employ this approach to study the conotoxins, a set of toxin peptides produced by the family of aquatic cone snails. Currently, of the approximately six thousand known conotoxin sequences, only about three percent have experimentally characterized three-dimensional structures, leading to a serious bottleneck in identifying potential drug candidates. We demonstrate that the conotoxin template library generated by our approach may be employed to perform homology modeling and greatly increase the number of characterized conotoxin structures. We also show how our approach can guide experimental design by identifying and ranking sequences for structural characterization in a similar manner. Overall, we present and validate an approach for venom structure modeling and employ it to expand the library of extant conotoxin structures by almost 300% through homology modeling employing the template library determined in our approach.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.